Dividend Channel
Market News Video Dividend Detective The Warren Buffetts Next Door Stock message boards

Contacting Dividend Channel

The best way to contact us at Dividend Channel is by phone at (516) 605-2277, 9AM to 5PM, Monday through Friday, closed market holidays. Thank you for your interest, and we look forward to speaking with you.


Thu, Jan 18, 9:04 AM, Zacks
BioLineRx Cancer Drug Positive as Monotherapy in Phase IIa
BioLineRx (BLRX) posts encouraging partial results from the monotherapy portion of a phase IIa COMBAT study, assessing its lead pipeline candidate, BL-8040, for pancreatic cancer patients.

Thu, Jan 18, 8:13 AM, Zacks
J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up?
The positive trend seen in J&J's (JNJ) pharma segment sales in Q3 is likely to continue in Q4. Strong pharma performance and contribution from acquisitions should support the top line.

Contact Dividend Channel | www.DividendChannel.com | Copyright © 2010 - 2018, All Rights Reserved

Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.